AT354421B - Verfahren zur herstellung von neuen substituierten 3-(3'-amino-2'-hydroxy- propoxyphenyl)-acrylsaeurederivaten - Google Patents

Verfahren zur herstellung von neuen substituierten 3-(3'-amino-2'-hydroxy- propoxyphenyl)-acrylsaeurederivaten

Info

Publication number
AT354421B
AT354421B AT370177A AT370177A AT354421B AT 354421 B AT354421 B AT 354421B AT 370177 A AT370177 A AT 370177A AT 370177 A AT370177 A AT 370177A AT 354421 B AT354421 B AT 354421B
Authority
AT
Austria
Prior art keywords
propoxyphenyl
hydroxy
amino
acrylic acid
acid derivatives
Prior art date
Application number
AT370177A
Other languages
German (de)
English (en)
Other versions
ATA370177A (de
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of AT354421B publication Critical patent/AT354421B/de
Publication of ATA370177A publication Critical patent/ATA370177A/de
Priority to AT519879A priority Critical patent/AT367742B/de
Priority to AT519779A priority patent/AT367757B/de
Priority to AT519979A priority patent/AT367743B/de
Priority to AT520079A priority patent/AT368484B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyridine Compounds (AREA)
AT370177A 1976-05-25 1977-05-24 Verfahren zur herstellung von neuen substituierten 3-(3'-amino-2'-hydroxy- propoxyphenyl)-acrylsaeurederivaten AT354421B (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AT519879A AT367742B (de) 1976-05-25 1979-07-27 Verfahren zur herstellung von neuen substituierten 3-(3'-amino-2'-hydroxypropoxyphenyl)-acrylsaeure derivaten sowie deren saeureadditionssalzen
AT519779A AT367757B (de) 1976-05-25 1979-07-27 Verfahren zur herstellung von neuen substituierten 3-(3'-amino-2'-hydroxypropoxyphenyl)-acrylsaeure derivaten sowie deren saeureadditionssalzen
AT519979A AT367743B (de) 1976-05-25 1979-07-27 Verfahren zur herstellung von neuen substituierten 3-(3'-amino-2'-hydroxypropoxyphenyl)-acrylsaeure derivaten sowie deren saeureadditionssalzen
AT520079A AT368484B (de) 1976-05-25 1979-07-27 Verfahren zur herstellung von neuen substituierten 3-(3'-amino-2'-hydroxypropoxyphenyl)acryls[urederivaten

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2623314A DE2623314C2 (de) 1976-05-25 1976-05-25 1-Aryloxy-2-Hydroxy-3-aminopropane, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
AT354421B true AT354421B (de) 1979-01-10
ATA370177A ATA370177A (de) 1979-06-15

Family

ID=5978907

Family Applications (1)

Application Number Title Priority Date Filing Date
AT370177A AT354421B (de) 1976-05-25 1977-05-24 Verfahren zur herstellung von neuen substituierten 3-(3'-amino-2'-hydroxy- propoxyphenyl)-acrylsaeurederivaten

Country Status (18)

Country Link
JP (1) JPS5312827A (sv)
AT (1) AT354421B (sv)
AU (1) AU511704B2 (sv)
BE (1) BE855041A (sv)
CA (1) CA1108633A (sv)
CH (5) CH637105A5 (sv)
DE (1) DE2623314C2 (sv)
DK (1) DK227177A (sv)
ES (1) ES458957A1 (sv)
FI (1) FI67698C (sv)
FR (1) FR2353520A1 (sv)
GB (1) GB1577670A (sv)
HU (1) HU179198B (sv)
IL (1) IL52148A (sv)
IT (1) IT1077193B (sv)
NL (1) NL7705587A (sv)
SE (1) SE440903B (sv)
ZA (1) ZA773120B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2415622A1 (fr) * 1978-01-25 1979-08-24 Lipha Amino alcools derives de l'ortho-hydroxy cinnamate de methyle applicables notamment comme medicaments
DE2824764A1 (de) * 1978-06-06 1979-12-20 Hoechst Ag Neue pyridylpiperazinderivate und verfahren zu ihrer herstellung
EP0008711B1 (en) * 1978-08-15 1981-11-04 Smithkline Beckman Corporation A method of preparing a 2-hydroxy-3-isopropyl or a 2-hydroxy-3-tert-butylaminopropyl aromatic ether
FR2459235A1 (fr) * 1979-06-14 1981-01-09 Sanofi Sa Nouveaux derives de sulfonyl-aniline, leur procede de preparation et leur application therapeutique
JPH0629833B2 (ja) * 1984-06-15 1994-04-20 株式会社島津製作所 疲労試験機
GB8603120D0 (en) * 1986-02-07 1986-03-12 Pfizer Ltd Anti-dysrhythmia agents
ATE303987T1 (de) 1999-05-24 2005-09-15 Mitsubishi Pharma Corp Phenoxypropylamin-derivate
DE19941657A1 (de) * 1999-09-01 2001-03-08 Schwabe Willmar Gmbh & Co Zimtsäurenitrile, Verfahren zu ihrer Herstellung und Verwendung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA945172A (en) * 1969-02-21 1974-04-09 Imperial Chemical Industries Limited Alkanolamine derivatives
FR2132570B1 (sv) * 1971-04-09 1974-08-02 Lipha
BE791650R (fr) * 1971-11-18 1973-05-21 Ici Ltd Derives d'alkanolamines.
ES411826A1 (es) * 1973-02-20 1976-01-01 Liade Sa Lab Procedimiento de obtencion de 1-ariloxi - 2 - propanolami- nas farmacologicamente activos.

Also Published As

Publication number Publication date
IL52148A0 (en) 1977-07-31
IL52148A (en) 1982-07-30
FR2353520B1 (sv) 1980-07-25
SE7706059L (sv) 1977-11-26
IT1077193B (it) 1985-05-04
CH640507A5 (en) 1984-01-13
CH637105A5 (en) 1983-07-15
JPS6214545B2 (sv) 1987-04-02
HU179198B (en) 1982-09-28
FI67698B (fi) 1985-01-31
AU2543477A (en) 1978-11-30
ES458957A1 (es) 1978-07-16
JPS5312827A (en) 1978-02-04
ZA773120B (en) 1978-04-26
SE440903B (sv) 1985-08-26
FR2353520A1 (fr) 1977-12-30
FI771630A (sv) 1977-11-26
BE855041A (fr) 1977-11-25
DE2623314A1 (de) 1977-12-08
DE2623314C2 (de) 1984-08-02
FI67698C (fi) 1985-05-10
CA1108633A (en) 1981-09-08
CH637107A5 (en) 1983-07-15
CH637108A5 (en) 1983-07-15
GB1577670A (en) 1980-10-29
AU511704B2 (en) 1980-09-04
CH637109A5 (en) 1983-07-15
DK227177A (da) 1977-11-26
ATA370177A (de) 1979-06-15
NL7705587A (nl) 1977-11-29

Similar Documents

Publication Publication Date Title
AT358557B (de) Verfahren zur herstellung von neuen substi- tuierten 3-phenoxy-phenylthioalkancarbonsaeure- derivaten
ATA38279A (de) Verfahren zur herstellung von neuen 3-(2'perhalogenalkylvinyl)-2,2-dimethylcyclopropancarbonsaeureestern
AT368168B (de) Verfahren zur herstellung von neuen thioetiansaeurederivaten
AT358728B (de) Verfahren zur herstellung von neuen synisomeren von 3,7-disubstituierten 3-cephem-4-carbon- saeureverbindungen
AT367430B (de) Verfahren zur herstellung von neuen hydroxylamino-hydrocarbylphosphonsaeurederivaten
AT369005B (de) Verfahren zur herstellung von neuen cephalosporan-saeurederivaten
AT359643B (de) Verfahren zur herstellung von neuen 4"-ery- thromycin-a-derivaten
AT354626B (de) Verfahren zur herstellung von neuen 7-acyl- amino-8-oxo-3-oxa-1-azabicyclo/4.2.0/octan-2- carbonsaeure-derivaten
AT367432B (de) Verfahren zur herstellung von neuen 3",4"diacyltylosinderivaten
AT354421B (de) Verfahren zur herstellung von neuen substituierten 3-(3'-amino-2'-hydroxy- propoxyphenyl)-acrylsaeurederivaten
AT356814B (de) Verfahren zur herstellung von neuen clavulan- saeurederivaten
AT365564B (de) Verfahren zur herstellung von neuen alpha-phenylbenzylidenaminoalkansaeurederivaten
AT363181B (de) Verfahren zur herstellung von neuen clavulansaeurederivaten
AT365170B (de) Verfahren zur herstellung von neuen 13-thiaprostansaeurederivaten
AT370106B (de) Verfahren zur herstellung von neuen penicillansaeurederivaten
AT363462B (de) Verfahren zur herstellung von neuen arylalkansaeurederivaten
ATA520079A (de) Verfahren zur herstellung von neuen substituierten 3-(3'-amino-2'-hydroxypropoxyphenyl)acrylsaeurederivaten
AT367758B (de) Verfahren zur herstellung von neuen 20-methyl-13, 14-didehydro-pgi 2-derivaten
ATA519979A (de) Verfahren zur herstellung von neuen substituierten 3-(3'-amino-2'-hydroxypropoxyphenyl)-acrylsaeure derivaten sowie deren saeureadditionssalzen
ATA519779A (de) Verfahren zur herstellung von neuen substituierten 3-(3'-amino-2'-hydroxypropoxyphenyl)-acrylsaeure derivaten sowie deren saeureadditionssalzen
ATA519879A (de) Verfahren zur herstellung von neuen substituierten 3-(3'-amino-2'-hydroxypropoxyphenyl)-acrylsaeure derivaten sowie deren saeureadditionssalzen
AT362877B (de) Verfahren zur herstellung von neuen 3,7disubstituierten 3-cephem-4-carbonsaeureverbindungen
ATA160879A (de) Verfahren zur herstellung von neuen 3,7-di- substituierten 3-cephem-4-carbonsaeurever- bindungen
ATA564679A (de) Verfahren zur herstellung von neuen hydroxylamino-hydrocarbylphosphonsaeurederivaten
ATA5381A (de) Verfahren zur herstellung von neuen 13-thiaprostansaeurederivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee